Quoin Pharmaceuticals (QNRX) Accounts Payables (2017 - 2026)
Quoin Pharmaceuticals (QNRX) posted Accounts Payables of $1.8 million for Q1 2026, up 40.72% sequentially from $1.3 million in Q4 2025, and up 175.79% YoY from $644057.0 in Q1 2025.
Quoin Pharmaceuticals (QNRX) Accounts Payables (2017 - 2026) Analysis & Trends
Quoin Pharmaceuticals has reported Accounts Payables for 10 years, with the latest figure at $1.8 million in Q1 2026.
- Quarterly Accounts Payables rose 175.79% year-over-year to $1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 million (up 175.79% YoY) and the FY2025 annual result came in at $1.3 million, up 39.36% from the prior year.
- Accounts Payables grew to $1.8 million in Q1 2026 per QNRX's latest filing, from $1.3 million in the prior quarter.
- Over five years, Accounts Payables peaked at $1.9 million in Q3 2025 and troughed at $222636.0 in Q3 2024.
- A 5-year average of $758370.9 and a median of $675996.0 in 2023 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2025: Accounts Payables sank 34.4% in 2022, then soared 735.77% in 2025.
- Over 5 years, Accounts Payables stood at $605600.0 in 2022, then retreated by 13.06% to $526523.0 in 2023, then surged by 72.02% to $905704.0 in 2024, then jumped by 39.36% to $1.3 million in 2025, then soared by 40.72% to $1.8 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.8 million, $1.3 million, and $1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 35.57 Mn |
| 10 | Quoin Pharmaceuticals | 531,643.73 | 531,643.73 | - | 3.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.78 Mn |
| Dec 31, 2025 | 1.26 Mn |
| Sep 30, 2025 | 1.86 Mn |
| Jun 30, 2025 | 873,684.00 |
| Mar 31, 2025 | 644,057.00 |
| Dec 31, 2024 | 905,704.00 |
| Sep 30, 2024 | 222,636.00 |
| Jun 30, 2024 | 819,674.00 |
| Mar 31, 2024 | 358,510.00 |
| Dec 31, 2023 | 526,523.00 |
| Sep 30, 2023 | 239,978.00 |
| Jun 30, 2023 | 707,935.00 |
| Mar 31, 2023 | 281,094.00 |
| Dec 31, 2022 | 605,600.00 |
| Sep 30, 2022 | 280,698.00 |
| Jun 30, 2022 | 768,670.00 |
| Dec 31, 2021 | 923,239.00 |
| Dec 31, 2020 | 875,000.00 |
| Jun 30, 2020 | 666,000.00 |
| Jun 30, 2019 | 1.04 Mn |